APA

Garrido P., Rosell R., Massutí B., Cardenal F., Alberola V., Dómine M., Maeztu I., Ramos A. & Arellano A. (20090630). Predictors of long-term survival in patients with lung cancer included in the randomized Spanish Lung Cancer Group 0008 phase II trial using concomitant chemoradiation with docetaxel and carboplatin plus induction or consolidation chemotherapy. : Clinical lung cancer.

Chicago

Garrido Pilar, Rosell Rafael, Massutí Bartomeu, Cardenal Felipe, Alberola Vicente, Dómine Manuel, Maeztu Inmaculada, Ramos Alfredo and Arellano Antonio. 20090630. Predictors of long-term survival in patients with lung cancer included in the randomized Spanish Lung Cancer Group 0008 phase II trial using concomitant chemoradiation with docetaxel and carboplatin plus induction or consolidation chemotherapy. : Clinical lung cancer.

Harvard

Garrido P., Rosell R., Massutí B., Cardenal F., Alberola V., Dómine M., Maeztu I., Ramos A. and Arellano A. (20090630). Predictors of long-term survival in patients with lung cancer included in the randomized Spanish Lung Cancer Group 0008 phase II trial using concomitant chemoradiation with docetaxel and carboplatin plus induction or consolidation chemotherapy. : Clinical lung cancer.

MLA

Garrido Pilar, Rosell Rafael, Massutí Bartomeu, Cardenal Felipe, Alberola Vicente, Dómine Manuel, Maeztu Inmaculada, Ramos Alfredo and Arellano Antonio. Predictors of long-term survival in patients with lung cancer included in the randomized Spanish Lung Cancer Group 0008 phase II trial using concomitant chemoradiation with docetaxel and carboplatin plus induction or consolidation chemotherapy. : Clinical lung cancer. 20090630.